H 
Hangzhou TianMuShan Pharmaceutical Enterprise Co 600671.SS · CNY
Health Care · Shanghai · 🇨🇳 China
17.32
-3.29%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥211.8m
FY2016FY2025
Net income
CN¥17.6m
FY2016FY2025
Free cash flow
−CN¥19.4m
FY2016FY2025
Shareholders' equity
CN¥70.0m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥211.8m | CN¥217.3m | CN¥121.8m | CN¥108.9m | CN¥147.1m | CN¥206.6m | CN¥297.1m | CN¥358.5m | CN¥176.4m | CN¥123.7m |
| Gross profit | CN¥101.1m | CN¥100.7m | CN¥23.4m | CN¥15.2m | CN¥40.6m | CN¥76.3m | CN¥142.1m | CN¥133.2m | CN¥69.4m | CN¥45.5m |
| Research and development | — | CN¥1.2m | CN¥482,216 | CN¥1.6m | CN¥1.3m | CN¥642,881 | CN¥4.8m | CN¥7.6m | CN¥210,154 | CN¥210,154 |
| Operating income | CN¥17.2m | CN¥30.3m | −CN¥37.6m | −CN¥65.0m | −CN¥38.0m | −CN¥56.7m | CN¥51.1m | CN¥8.3m | CN¥19.2m | CN¥11.2m |
| Net income | CN¥17.6m | CN¥15.2m | −CN¥38.3m | −CN¥67.5m | −CN¥29.8m | −CN¥40.5m | CN¥50.7m | −CN¥9.9m | CN¥8.1m | CN¥1.2m |
| Diluted earnings per share | 0.14 | 0.13 | -0.31 | -0.55 | -0.23 | -0.32 | 0.42 | -0.09 | 0.08 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥442.0m | CN¥441.5m | CN¥346.3m | CN¥299.8m | CN¥402.6m | CN¥442.5m | CN¥526.9m | CN¥480.6m | CN¥450.4m | CN¥306.2m |
| Cash and short-term investments | — | CN¥65.7m | CN¥98.0m | CN¥42.4m | CN¥22.3m | CN¥7.6m | CN¥25.7m | CN¥86.8m | CN¥40.6m | CN¥29.8m |
| Total liabilities | CN¥348.0m | CN¥356.4m | CN¥290.3m | CN¥295.4m | CN¥338.1m | CN¥349.2m | CN¥393.6m | CN¥399.0m | CN¥354.2m | CN¥240.0m |
| Debt | — | CN¥137.2m | CN¥109.9m | CN¥116.0m | CN¥112.8m | CN¥113.8m | CN¥88.5m | CN¥109.4m | CN¥132.5m | CN¥128.5m |
| Shareholders' equity | CN¥70.0m | CN¥52.4m | CN¥37.1m | −CN¥14.6m | CN¥45.2m | CN¥72.8m | CN¥101.8m | CN¥51.5m | CN¥66.1m | CN¥59.0m |
| Shares outstanding | 122m | 121m | 122m | 122m | 131m | 126m | 121m | 115m | 100m | 121m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥11.8m | −CN¥36.7m | −CN¥20.4m | −CN¥19.4m | −CN¥26.4m | −CN¥8.4m | CN¥161.1m | CN¥70.7m | CN¥24.5m | CN¥1.6m |
| Capital spending | −CN¥31.2m | −CN¥20.6m | −CN¥9.0m | −CN¥3.5m | −CN¥4.7m | −CN¥11.8m | −CN¥94.7m | −CN¥37.5m | −CN¥62.2m | −CN¥25.2m |
| Free cash flow | −CN¥19.4m | −CN¥57.2m | −CN¥29.4m | −CN¥22.9m | −CN¥31.1m | −CN¥20.2m | CN¥66.5m | CN¥33.2m | −CN¥37.7m | −CN¥23.6m |
| Dividends paid | −CN¥6.5m | −CN¥8.6m | −CN¥6.7m | −CN¥4.8m | −CN¥6.7m | −CN¥7.0m | −CN¥6.1m | −CN¥9.2m | −CN¥8.8m | −CN¥7.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥55.0m | CN¥44.4m | CN¥52.8m | CN¥55.3m | CN¥51.3m | CN¥52.3m | CN¥92.6m | CN¥65.1m |
| Gross profit | CN¥25.7m | CN¥24.3m | CN¥27.4m | CN¥30.6m | CN¥21.7m | CN¥21.4m | CN¥47.4m | CN¥37.4m |
| Operating income | CN¥3.4m | CN¥6.5m | CN¥2.0m | CN¥4.5m | CN¥4.5m | CN¥4.5m | CN¥32.4m | CN¥18.3m |
| Net income | CN¥2.5m | CN¥3.8m | CN¥3.4m | CN¥4.0m | CN¥5.2m | CN¥5.1m | CN¥18.9m | CN¥14.8m |
| Diluted earnings per share | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.16 | 0.12 |
| Cash from operations | — | — | — | −CN¥19.0m | −CN¥1.0m | −CN¥9.0m | — | −CN¥10.0m |
| Capital spending | −CN¥4.0m | −CN¥3.0m | −CN¥4.0m | −CN¥7.0m | −CN¥14.0m | −CN¥4.0m | −CN¥8.0m | −CN¥8.0m |
| Free cash flow | — | — | — | −CN¥26.0m | −CN¥15.0m | −CN¥13.0m | — | −CN¥18.0m |
| Total assets | CN¥452.1m | CN¥464.9m | CN¥442.0m | CN¥429.7m | CN¥404.7m | CN¥430.2m | CN¥441.5m | CN¥366.4m |
| Cash and short-term investments | — | — | — | CN¥11.7m | CN¥25.4m | CN¥36.7m | CN¥65.7m | CN¥30.4m |
| Debt | — | — | — | CN¥167.2m | CN¥132.6m | CN¥124.8m | CN¥126.9m | CN¥87.5m |
| Shareholders' equity | CN¥76.3m | CN¥73.8m | CN¥70.0m | CN¥66.6m | CN¥62.6m | CN¥57.5m | CN¥52.4m | CN¥33.4m |
Financial ratios
Data as of 27 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 47.8% | 46.3% | 19.2% | 13.9% | 27.6% | 36.9% | — |
| Operating margin | 8.2% | 16.0% | -23.9% | -59.6% | -17.8% | -21.0% | — |
| Net margin | 8.3% | 7.0% | -31.4% | -62.0% | -20.3% | -19.6% | — |
| Return on equity | 25.2% | 29.1% | -103.1% | 461.6% | -66.0% | -55.6% | — |
| Return on assets | 4.0% | 3.5% | -11.1% | -22.5% | -7.4% | -9.2% | — |
| Free cash flow yield | 1.9% | -0.7% | -0.5% | -0.7% | -0.9% | 0.1% | — |
| Revenue growth | -2.6% | 78.4% | 11.8% | -25.9% | -28.8% | -30.4% | — |
| Earnings growth | 15.6% | -139.8% | -43.3% | 126.6% | -26.4% | -179.9% | — |
| Current ratio | 0.81x | 0.78x | 0.82x | 0.56x | 0.74x | 0.89x | — |
| Debt to equity | — | 2.42x | 2.76x | -7.42x | 2.39x | 2.12x | 1.05x |
| Equity ratio | 15.8% | 11.9% | 10.7% | -4.9% | 11.2% | 16.5% | — |
| Interest coverage | 2.42x | 6.14x | -4.01x | -8.72x | -3.49x | -6.11x | — |
| R&D as a share of sales | — | 0.6% | 0.4% | 1.5% | 0.9% | 0.3% | 1.6% |
| Buybacks as a share of market value | -0.5% | 0.5% | 0.0% | 7.2% | -4.3% | -3.9% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 24.8% | 0.5% | 8.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 47.0% | 36.4% | 35.3% | 37.6% |
| Operating margin | 11.1% | -8.3% | -14.8% | -3.9% |
| Net margin | 7.7% | -11.1% | -14.1% | -5.6% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 119.7 | 69.8 | -37.1 | -17.2 | -39.5 | -26.7 | 29.4 | -186.5 | 309.8 | — |
| Price to sales | 10.0 | 4.9 | 11.7 | 10.6 | 8.0 | 5.2 | 5.0 | 5.1 | 14.3 | 30.2 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 24 Aug 2005.
| FY2005 | FY2002 | FY2001 | FY1999 | FY1998 | FY1995 | |
|---|---|---|---|---|---|---|
| Paid in the year | 0.18 | 0.01 | 0.02 | 0.10 | 0.10 | 0.115 |
- 1-to-1 reverse split · 12 Jun 2009
- 1-to-1 reverse split · 18 Dec 2006
- 3-for-2 split · 24 Feb 1997
- 29-for-25 split · 19 Jul 1996
- 1.484-for-1 split · 6 Jun 1994
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.